List of Galectin Therapeutics patents

Patent 11413303 was granted and assigned to Galectin Therapeutics on August, 2022 by the United States Patent and Trademark Office.

Patent 9649327 was granted and assigned to Galectin Therapeutics on May, 2017 by the United States Patent and Trademark Office.

Patent 8962824 was granted and assigned to Galectin Therapeutics on February, 2015 by the United States Patent and Trademark Office.

Patent 9974802 was granted and assigned to Galectin Therapeutics on May, 2018 by the United States Patent and Trademark Office.

Patent 9763974 was granted and assigned to Galectin Therapeutics on September, 2017 by the United States Patent and Trademark Office.

Patent 10420793 was granted and assigned to Galectin Therapeutics on September, 2019 by the United States Patent and Trademark Office.

Patent 9339515 was granted and assigned to Galectin Therapeutics on May, 2016 by the United States Patent and Trademark Office.

Patent 8828971 was granted and assigned to Galectin Therapeutics on September, 2014 by the United States Patent and Trademark Office.

Patent 9968631 was granted and assigned to Galectin Therapeutics on May, 2018 by the United States Patent and Trademark Office.

Patent 9200090 was granted and assigned to Galectin Therapeutics on December, 2015 by the United States Patent and Trademark Office.

Patent 8722645 was granted and assigned to Galectin Therapeutics on May, 2014 by the United States Patent and Trademark Office.

Patent 8871925 was granted and assigned to Galectin Therapeutics on October, 2014 by the United States Patent and Trademark Office.

Patent 8658787 was granted and assigned to Galectin Therapeutics on February, 2014 by the United States Patent and Trademark Office.

Patent 8367638 was granted and assigned to Galectin Therapeutics on February, 2013 by the United States Patent and Trademark Office.